Partial response | 8 (21.6%) |
Stable disease | 12 (32.4%) |
Progressive disease | 11 (29.7%) |
Not evaluated | 6 (16.2%) |
Objective RR (95% CI) | 21.6% (11.4 - 37.2) |
Disease control rate (95% CI) | 54.1% (35.9 - 66.6) |
1-year survival | 56.6% (38.4 - 71.2) |
Median PFS (95% CI) Non-selected EGFR mutated EGFR wild-type EGFR unknown | 4.4 months (2.2 - 10.7) 12.6 months (2.2 - 19.9) 2.1 months (1.0 - 5.5) 3.9 months (1.0 - 11.0) |
Median OS (95% CI) Non-selected EGFR mutated EGFR wild-type EGFR unknown | 14.9 months (9.2 - NR) NR (5.3 - NR) 9.2 months (2.3 - 14.9) 10.5 months (1.1 - NR) |